NRG BN007

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Brain

Status:

Temporarily Closed

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients with Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma

NCT#04396860

BN007 is temporarily closed to accrual effective April 27, 2022 at 5pm ET.